186 related articles for article (PubMed ID: 30732736)
1. Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device Trials.
Ghare MI; Chandrasekhar J; Mehran R; Ng V; Grines C; Lansky A
JACC Cardiovasc Interv; 2019 Feb; 12(3):301-308. PubMed ID: 30732736
[TBL] [Abstract][Full Text] [Related]
2. Boosting Women's Participation in Cardiovascular Trials: More Work Needed to Match Real-World Epidemiology for Heart Failure, Coronary Artery Disease, and Acute Coronary Syndrome.
Kuehn BM
Circulation; 2018 Sep; 138(13):1366-1367. PubMed ID: 30354415
[No Abstract] [Full Text] [Related]
3. Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative.
Warner JJ; Crook HL; Whelan KM; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; Hernandez AF; McClellan MB; Califf RM; Brown N;
Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006606. PubMed ID: 32683985
[TBL] [Abstract][Full Text] [Related]
4. Overcoming Lack of Diversity in Cardiovascular Clinical Trials: A New Challenge and Strategies for Success.
Ortega RF; Yancy CW; Mehran R; Batchelor W
Circulation; 2019 Nov; 140(21):1690-1692. PubMed ID: 31738602
[No Abstract] [Full Text] [Related]
5. Status of women in cardiovascular clinical trials.
Kim ES; Menon V
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):279-83. PubMed ID: 19221204
[No Abstract] [Full Text] [Related]
6. Sex and cardiovascular disease status differences in attitudes and willingness to participate in clinical research studies/clinical trials.
Gruca TS; Hottel WJ; Comstock J; Olson A; Rosenthal GE
Trials; 2018 May; 19(1):300. PubMed ID: 29843818
[TBL] [Abstract][Full Text] [Related]
7. The impact of cardiovascular disease prevalence on women's enrollment in landmark randomized cardiovascular trials: a systematic review.
Tsang W; Alter DA; Wijeysundera HC; Zhang T; Ko DT
J Gen Intern Med; 2012 Jan; 27(1):93-8. PubMed ID: 21713543
[TBL] [Abstract][Full Text] [Related]
8. Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives.
Cho L; Vest AR; O'Donoghue ML; Ogunniyi MO; Sarma AA; Denby KJ; Lau ES; Poole JE; Lindley KJ; Mehran R;
J Am Coll Cardiol; 2021 Aug; 78(7):737-751. PubMed ID: 34384555
[TBL] [Abstract][Full Text] [Related]
9. Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017.
Jin X; Chandramouli C; Allocco B; Gong E; Lam CSP; Yan LL
Circulation; 2020 Feb; 141(7):540-548. PubMed ID: 32065763
[TBL] [Abstract][Full Text] [Related]
10. Evolution of Age and Female Representation in the Most-Cited Randomized Controlled Trials of Cardiology of the Last 20 Years.
Nguyen QD; Peters E; Wassef A; Desmarais P; Rémillard-Labrosse D; Tremblay-Gravel M
Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004713. PubMed ID: 29853466
[TBL] [Abstract][Full Text] [Related]
11. Why do patients participate in long-term cardiovascular trials?--a questionnaire-based study.
Dellborg H; Hultsberg-Olsson G; Dellborg M
Scand Cardiovasc J; 2016; 50(2):83-7. PubMed ID: 26686535
[TBL] [Abstract][Full Text] [Related]
12. Representation of women in randomized clinical trials of cardiovascular disease prevention.
Melloni C; Berger JS; Wang TY; Gunes F; Stebbins A; Pieper KS; Dolor RJ; Douglas PS; Mark DB; Newby LK
Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):135-42. PubMed ID: 20160159
[TBL] [Abstract][Full Text] [Related]
13. Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps.
Aggarwal NR; Patel HN; Mehta LS; Sanghani RM; Lundberg GP; Lewis SJ; Mendelson MA; Wood MJ; Volgman AS; Mieres JH
Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e004437. PubMed ID: 29449443
[TBL] [Abstract][Full Text] [Related]
14. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute.
Harris DJ; Douglas PS
N Engl J Med; 2000 Aug; 343(7):475-80. PubMed ID: 10944565
[TBL] [Abstract][Full Text] [Related]
15. Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial.
Zanni MV; Fitch K; Rivard C; Sanchez L; Douglas PS; Grinspoon S; Smeaton L; Currier JS; Looby SE
HIV Clin Trials; 2017 Mar; 18(2):83-91. PubMed ID: 28277924
[TBL] [Abstract][Full Text] [Related]
16. Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.
Aristizabal P; Singer J; Cooper R; Wells KJ; Nodora J; Milburn M; Gahagan S; Schiff DE; Martinez ME
Pediatr Blood Cancer; 2015 Aug; 62(8):1337-44. PubMed ID: 25755225
[TBL] [Abstract][Full Text] [Related]
17. Health disparities: a barrier to high-quality care.
Mullins CD; Blatt L; Gbarayor CM; Yang HW; Baquet C
Am J Health Syst Pharm; 2005 Sep; 62(18):1873-82. PubMed ID: 16141106
[TBL] [Abstract][Full Text] [Related]
18. Women and cardiovascular disease: an evidentiary review.
Shirato S; Swan BA
Medsurg Nurs; 2010; 19(5):282-6, 306. PubMed ID: 21189741
[TBL] [Abstract][Full Text] [Related]
19. Health inequalities in secondary prevention.
Oertelt-Prigione S; Maas AH
Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):116-122. PubMed ID: 28618901
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
